SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
AUXILIUM PHARMACEUTICALS
(NQNM:AUXL Last Sale: 18.27 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (AUXL : $18.27)
$780 million Market Cap at September 12, 2013
Employs 175.
Personal Products SubIndustry up .00% / Consumer Products & Services Industry up .00% Today
40 Valley Stream Parkway Research Report Earnings Snapshot - Last 10/30/18
Malvern, PA 19355 Fact Sheet
Phone: 484-321-5900 Financial Statements
Peer Comparison
Annual Reports

Armando Anido, CEO, James E. Fickenscher, CFO
Develops and markets products for urologic and sexual health. Markets one product through a 100 person sales organization and has 3 products in development. Testim, is a topical 1% testosterone gel indicated for the treatment of hypogonadism, a disorder that affects approximately 20% of the U.S. male population over age 50. IPO at $7.50 July 22, 2004. Raised $41.3 million, selling 5.5 million shares, 26% of the outstanding. Lead Manager: Deutsche Bank.
Historical Charts    Technical Analysis
No Historical Data available for AUXL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AUXL $18.27 $ 0 $18.1701 $18.54 559,976 $13.87 $25.54 42,690
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $779,946

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex